Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR3519)
Drug Name
Finerenone
Synonyms
UNII-DE2O63YV8R; BAY 94-8862; 1050477-31-0; BAY94-8862; DE2O63YV8R; Finerenone [USAN:INN]; Finerenone (JAN/USAN/INN); SCHEMBL8157011; GTPL8678; DTXSID10146928; J3.584.878I; D10633; 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-;1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-; 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-; (4S)-4-(4-cyano-2-metho
Indication Diabetic nephropathy [ICD11: GB61] Phase 3 [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 378.4 Topological Polar Surface Area 110
Heavy Atom Count 28 Rotatable Bond Count 5
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
60150535
CAS Number
1050477-31-0
TTD Drug ID
D0NV5O
Formula
C21H22N4O3
Canonical SMILES
CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
InChI
InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1
InChIKey
BTBHLEZXCOBLCY-QGZVFWFLSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Finerenone M1 Metabolite DM005051
126623403
Other reaction - Aromatization 1 [2] , [4] , [5]
Finerenone M10 Metabolite DM005059 N. A. Oxidation - Demethylation 1 [2]
Finerenone M13 Metabolite DM005057 N. A. Oxidation - O-deethylation 1 [2] , [4]
Finerenone M14 Metabolite DM005058 N. A. Unclear 1 [2] , [4] , [5]
Finerenone M4 Metabolite DM005054
156613671
Oxidation - Epoxidation; hydroxylation 1 [2] , [5]
Finerenone M7 Metabolite DM005060 N. A. Unclear 1 [2]
Finerenone M9 Metabolite DM005061 N. A. Unclear 1 [2]
Finerenone M2 Metabolite DM005052
126623573
Oxidation - Hydrolyzationn 2 [3]
Finerenone M5 Metabolite DM005055
156596817
Oxidation - Hydrolyzationn 2 [3]
Finerenone M3 Metabolite DM005053
126623492
Oxidation - Oxidationn 3 [3]
Finerenone M8 Metabolite DM005056
155929011
Oxidation - Oxidationn 3 [3]
⏷ Show the Full List of 11  DM(s)
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR005478 Finerenone Finerenone M1 Metabolite Other reaction - Aromatization CYP3A4 ... [2], [4], [5]
MR005481 Finerenone Finerenone M4 Metabolite Oxidation - Epoxidation; hydroxylation CYP3A4 ... [2], [5]
MR005484 Finerenone Finerenone M13 Metabolite Oxidation - O-deethylation CYP3A4 [2], [4]
MR005485 Finerenone Finerenone M14 Metabolite Unclear CYP3A4 ... [2], [4], [5]
MR005486 Finerenone Finerenone M10 Metabolite Oxidation - Demethylation Unclear [2]
MR005487 Finerenone Finerenone M7 Metabolite Unclear CYP2C8 [2]
MR005488 Finerenone Finerenone M9 Metabolite Unclear Unclear [2]
MR005479 Finerenone M1 Metabolite Finerenone M2 Metabolite Oxidation - Hydrolyzationn CYP3A4 [3]
MR005482 Finerenone M4 Metabolite Finerenone M5 Metabolite Oxidation - Hydrolyzationn CYP3A4 [3]
MR005480 Finerenone M2 Metabolite Finerenone M3 Metabolite Oxidation - Oxidationn CYP3A4 [3]
MR005483 Finerenone M5 Metabolite Finerenone M8 Metabolite Oxidation - Oxidationn Unclear [3]
⏷ Show the Full List of 11 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 1A1 (CYP1A1) DME0006 Homo sapiens
CP1A1_HUMAN
1.14.14.1
[2]
Cytochrome P450 1A1 (CYP1A1) DME0006 Homo sapiens
CP1A1_HUMAN
1.14.14.1
[3]
Cytochrome P450 2C8 (CYP2C8) DME0018 Homo sapiens
CP2C8_HUMAN
1.14.14.1
[2] , [4] , [5]
Cytochrome P450 2C8 (CYP2C8) DME0018 Homo sapiens
CP2C8_HUMAN
1.14.14.1
[2]
Cytochrome P450 2C8 (CYP2C8) DME0018 Homo sapiens
CP2C8_HUMAN
1.14.14.1
[5]
Cytochrome P450 2C8 (CYP2C8) DME0018 Homo sapiens
CP2C8_HUMAN
1.14.14.1
[6]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[2] , [4] , [5]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[5]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[7]
⏷ Show the Full List of 9  DME(s)
References
1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro
3 DrugBank(Pharmacology-Metabolism):Finerenone
4 Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present
5 Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3
6 Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug-Drug Interaction Studies In Vitro and In Vivo
7 Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.